BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 33261583)

  • 21. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
    Liu Y; Liao W; Wan L; Xiang T; Zhang W
    Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
    Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
    Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous tracking of COVID-19 patients' immune status.
    Guan J; Wei X; Qin S; Liu X; Jiang Y; Chen Y; Chen Y; Lu H; Qian J; Wang Z; Lin X
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107034. PubMed ID: 33039966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased circulating level of interleukin-6 and CD8
    Yang PH; Ding YB; Xu Z; Pu R; Li P; Yan J; Liu JL; Meng FP; Huang L; Shi L; Jiang TJ; Qin EQ; Zhao M; Zhang DW; Zhao P; Yu LX; Wang ZH; Hong ZX; Xiao ZH; Xi Q; Zhao DX; Yu P; Zhu CZ; Chen Z; Zhang SG; Ji JS; Wang FS; Cao GW
    Infect Dis Poverty; 2020 Nov; 9(1):161. PubMed ID: 33239109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.
    Hammad R; Eldosoky MAER; Fouad SH; Elgendy A; Tawfeik AM; Alboraie M; Abdelmaksoud MF
    Innate Immun; 2021 Apr; 27(3):240-250. PubMed ID: 33646058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of lymphocyte subpopulations in the peripheral blood of patients with COVID-19: Implications for disease severity and prognosis.
    Xu X; Huang J; Zhang H; Lu W; Liu J
    Immun Inflamm Dis; 2024 May; 12(5):e1281. PubMed ID: 38780019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients.
    Caldrer S; Mazzi C; Bernardi M; Prato M; Ronzoni N; Rodari P; Angheben A; Piubelli C; Tiberti N
    Front Immunol; 2021; 12():789735. PubMed ID: 34925369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
    Deng LS; Yuan J; Ding L; Chen YL; Zhao CH; Chen GQ; Li XH; Li XH; Luo WT; Lan JF; Tan GY; Tang SH; Xia JY; Liu X
    Infect Dis Poverty; 2020 Dec; 9(1):163. PubMed ID: 33261654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
    Yu HB; Wang WJ; Tang S; Chen DX; Xu B
    J Med Virol; 2021 Feb; 93(2):760-765. PubMed ID: 32644266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses.
    Fox A; Le NM; Horby P; van Doorn HR; Nguyen VT; Nguyen HH; Nguyen TC; Vu DP; Nguyen MH; Diep NT; Bich VT; Huong HT; Taylor WR; Farrar J; Wertheim H; Nguyen VK
    PLoS One; 2012; 7(2):e31535. PubMed ID: 22363665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.
    Auvinen R; Nohynek H; Syrjänen R; Ollgren J; Kerttula T; Mäntylä J; Ikonen N; Loginov R; Haveri A; Kurkela S; Skogberg K
    Infect Dis (Lond); 2021 Feb; 53(2):111-121. PubMed ID: 33170050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between T lymphocyte subsets and different syndrome types in patients with influenza A (H1N1): a retrospective study].
    Huang Y; Zeng X; Zhu W; Li SS; Zhou D; Lu CJ
    Zhong Xi Yi Jie He Xue Bao; 2011 Feb; 9(2):143-7. PubMed ID: 21288448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report.
    Hu C; Li J; Xing X; Gao J; Zhao S; Xing L
    PLoS One; 2021; 16(3):e0248675. PubMed ID: 33735325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
    Montiel-Cervantes LA; Medina G; Pilar Cruz-Domínguez M; Pérez-Tapia SM; Jiménez-Martínez MC; Arrieta-Oliva HI; Carballo-Uicab G; López-Pelcastre L; Camacho-Sandoval R
    Isr Med Assoc J; 2021 Mar; 23(3):153-159. PubMed ID: 33734627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients.
    Kwiecień I; Rutkowska E; Kłos K; Więsik-Szewczyk E; Jahnz-Różyk K; Rzepecki P; Chciałowski A
    Cells; 2020 Dec; 9(12):. PubMed ID: 33291439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.